Summary: Listen to MAPS Founder and Executive Director Rick Doblin, Ph.D., discuss MAPS-sponsored clinical trials of MDMA-assisted therapy for the treatment of posttraumatic stress disorder (PTSD) and his personal path to pursuing psychedelic research on The Depression Files podcast with Al Levin.
Originally appearing here.
In this interview, Al interviews Dr. Rick Doblin, founder and executive director of the Multidisciplinary Association for Psychedelic Studies (MAPS), on the topic of MDMA research for the treatment of Post-Traumatic Stress Disorder (PTSD).
Rick shares some incredibly personal stories related to how he became involved and interested in psychedelics, including the story of a college counselor who shared a book with him in order to improve his psychedelic “trips”.
Hear how MAPS was able to receive U.S. Food and Drug Administration (FDA) Breakthrough Therapy Designation for MDMA-Assisted Therapy for PTSD in 2017 and much, much more!